Rite Aid Corp (RTA1.BE)
| Previous close | 0.3400 |
| Open | 0.3420 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 0.3400 - 0.3420 |
| 52-week range | 0.1420 - 2.7800 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Bloomberg
Rite Aid CEO’s $20 Million Pay Spurs Lender Backlash
(Bloomberg) -- Rite Aid Corp.’s main lenders are demanding a proposed $20 million payout to Chief Executive Officer Jeffrey Stein be reduced before they fund the company’s exit from bankruptcy, according to people with knowledge of the situation.Most Read from BloombergBehind ‘Suicide Squad,’ the Year’s Biggest Video-Game FlopBillionaire-Friendly Modi Humbled by Indians Who Make $4 a DayA Struggling Business Park Deals a Blow to Singapore's Regional Hub Ambitions‘Everything Is Not Going to Be OK
- Reuters
Bankrupt Rite Aid resolves drug supply dispute with McKesson
Pharmacy chain Rite Aid has settled a critical dispute with drug supplier McKesson Corp to ensure that customers' prescriptions will continue to be filled during Rite Aid's bankruptcy, attorneys said on Tuesday. Rite Aid, which filed for Chapter 11 bankruptcy on Sunday night in New Jersey, sued McKesson the following morning, seeking to stop it from terminating a drug supply agreement that accounts for 98% of the pharmacy chain's prescription drug sales. Joshua Sussberg, an attorney for Rite Aid, announced the settlement at a Tuesday court hearing in Trenton, saying that McKesson would continue supplying drugs at least through the end of Rite Aid's bankruptcy case.
- GOBankingRates
Should You Expect Sales as Rite Aid Files for Bankruptcy?
Rite Aid filed for Chapter 11 bankruptcy protection while dealing with losses from opioid-related lawsuits. Other brick-and-mortar retailers have experienced the same fate in recent years. If Rite Aid...
